AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Texas Instruments
TXN
|
$792M |
| 2 |
Home Depot
HD
|
$649M |
| 3 |
Netflix
NFLX
|
$612M |
| 4 |
West Pharmaceutical
WST
|
$528M |
| 5 |
Zoetis
ZTS
|
$444M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$1.27B |
| 2 |
MSCI
MSCI
|
$807M |
| 3 |
Fortinet
FTNT
|
$765M |
| 4 |
Nike
NKE
|
$707M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$534M |
Sector Composition
| 1 | Technology | 29.82% |
| 2 | Healthcare | 15.99% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.41% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
3201
Franklin Street Properties
FSP
$177M
| $41.8K | ﹤0.01% |
+27,300
| New | +$41.8K |
|
3202
Verastem
VSTM
$681M
| $41.4K | ﹤0.01% |
+13,880
| New | +$41.4K |
|
|
SLSR
3203
Solaris Resources
SLSR
$869M
| $39.7K | ﹤0.01% |
+14,240
| New | +$39.7K |
|
3204
Ovid Therapeutics
OVID
$89.6M
| $36.8K | ﹤0.01% |
+47,880
| New | +$36.8K |
|
3205
Waldencast
WALD
$205M
| $36.5K | ﹤0.01% |
+10,180
| New | +$36.5K |
|
|
QIPT
3206
Quipt Home Medical
QIPT
$113M
| $35.6K | ﹤0.01% |
+11,050
| New | +$35.6K |
|
3207
ThredUp
TDUP
$1.42B
| $34.5K | ﹤0.01% |
+20,310
| New | +$34.5K |
|
3208
Rekor Systems
REKR
$138M
| $32.1K | ﹤0.01% |
+20,700
| New | +$32.1K |
|
3209
Allbirds
BIRD
$52.3M
| $30.7K | ﹤0.01% |
3,071
-160
| -5% | -$1.6K |
|
3210
Veru
VERU
$48.3M
| $30.2K | ﹤0.01% |
+3,588
| New | +$30.2K |
|
|
KG
3211
Kestrel Group, Ltd.
KG
$201M
| $29.9K | ﹤0.01% |
+727
| New | +$29.9K |
|
3212
MarketWise
MKTW
$49.9M
| $29.8K | ﹤0.01% |
1,286
+357
| +38% | +$8.28K |
|
3213
Motorsport Games
MSGM
$14.9M
| $29.2K | ﹤0.01% |
12,216
| – | – |
|
3214
Porch Group
PRCH
$1.92B
| $28.7K | ﹤0.01% |
+18,980
| New | +$28.7K |
|
|
NAGE
3215
Niagen Bioscience, Inc. Common Stock
NAGE
$735M
| $27.4K | ﹤0.01% |
+10,050
| New | +$27.4K |
|
3216
Ginkgo Bioworks
DNA
$635M
| $27.2K | ﹤0.01% |
2,032
-9,467
| -82% | -$127K |
|
3217
Tilray
TLRY
$1.29B
| $24.4K | ﹤0.01% |
14,710
| – | – |
|
3218
Compass Therapeutics
CMPX
$599M
| $24.2K | ﹤0.01% |
24,180
+10,700
| +79% | +$10.7K |
|
|
FIACW
3219
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
| $23.8K | ﹤0.01% |
19,700
| – | – |
|
3220
Cardiff Oncology
CRDF
$144M
| $23K | ﹤0.01% |
+10,380
| New | +$23K |
|
3221
Atossa Therapeutics
ATOS
$101M
| $20.7K | ﹤0.01% |
+17,380
| New | +$20.7K |
|
3222
Kaltura
KLTR
$232M
| $20.4K | ﹤0.01% |
+16,980
| New | +$20.4K |
|
3223
Solidion Technology
STI
$18.3M
| $15.1K | ﹤0.01% |
+550
| New | +$15.1K |
|
|
DADA
3224
DELISTED
Dada Nexus
DADA
| $14.8K | ﹤0.01% |
11,727
| – | – |
|
|
LILM
3225
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $14.4K | ﹤0.01% |
18,064
| – | – |
|